WallStreetZenWallStreetZen

NASDAQ: AMLX
Amylyx Pharmaceuticals Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Amylyx Pharmaceuticals earnings were -$144.7M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest AMLX earnings report on Dec 31, 2025 announced Q4 2025 earnings of -$33.0M, down 4% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, AMLX reported annual earnings of -$144.7M, with -52% growth. The next AMLX earnings date is Apr 1, 2026.

AMLX earnings history

Current Revenue
$0.0
Current Earnings
-$144.7M
Current Profit Margin
0%

AMLX Return on Equity

Current Company
-57.5%
Current Industry
-9.4%
Current Market
29.5%
AMLX's Return on Equity (-57.5%)... subscribe to Premium to read more.
High Return on Equity Performance

AMLX Return on Assets

Current Company
-52.2%
Current Industry
-6.2%
AMLX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when AMLX announces earnings.

AMLX Return on Capital Employed

Current Company
-46.68%
Current Industry
-0.5%
AMLX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

AMLX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
AMLX-$144.16M-$144.74MN/A-$1.53
NRIX-$244.84M-$264.46MN/A-$3.05
NUVB-$188.93M-$204.63MN/A-$0.60
IMCR-$1.32M-$35.51MN/A-$0.71
NTLA-$396.77M-$412.69MN/A-$3.81
View Top Biotech Stocks

AMLX earnings dates

Next earnings date
Apr 1, 2026

Amylyx Pharmaceuticals Earnings Reports & History FAQ

What were Amylyx Pharmaceuticals's earnings last quarter?

Amylyx Pharmaceuticals (NASDAQ: AMLX) reported Q4 2025 earnings per share (EPS) of -$0.28, up 48.15% year over year. Total AMLX earnings for the quarter were -$33.00 million. In the same quarter last year, Amylyx Pharmaceuticals's earnings per share (EPS) was -$0.54.

If you're new to stock investing, here's how to buy Amylyx Pharmaceuticals stock.

When does Amylyx Pharmaceuticals report earnings?

The next AMLX earnings date is Invalid Date. Add AMLX to your watchlist to be reminded of Amylyx Pharmaceuticals's next earnings date.

Is Amylyx Pharmaceuticals profitable or losing money?

As of the last Amylyx Pharmaceuticals earnings report, Amylyx Pharmaceuticals is currently losing money. Amylyx Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$144.74 million, a 52.03% decrease year over year.

What was AMLX's earnings growth in the past year?

As of Amylyx Pharmaceuticals's earnings date in Q1 2026, Amylyx Pharmaceuticals's earnings has grown year over year. AMLX earnings in the past year totalled -$144.74 million.

What are Amylyx Pharmaceuticals's earnings expectations?

The current EPS estimate for Amylyx Pharmaceuticals's earnings report in Invalid Date is -$0.34.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.